Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
50.22 x 1 50.40 x 13
Post-market by (Cboe BZX)
50.46 -3.28 (-6.10%) 04/10/25 [NYSE]
50.22 x 1 50.40 x 13
Post-market 50.30 -0.16 (-0.32%) 19:57 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
48.82
Day High
53.42
Open 53.33
Previous Close 53.74 53.74
Volume 23,973,300 23,973,300
Avg Vol 13,544,095 13,544,095
Stochastic %K 18.33% 18.33%
Weighted Alpha +0.42 +0.42
5-Day Change -7.36 (-12.73%) -7.36 (-12.73%)
52-Week Range 39.35 - 63.33 39.35 - 63.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 109,348,160
  • Shares Outstanding, K 2,034,763
  • Annual Sales, $ 48,300 M
  • Annual Income, $ -8,948 M
  • EBIT $ 493 M
  • EBITDA $ 10,093 M
  • 60-Month Beta 0.41
  • Price/Sales 2.24
  • Price/Cash Flow 9.01
  • Price/Book 6.57

Options Overview Details

View History
  • Implied Volatility 55.70% ( +10.17%)
  • Historical Volatility 34.18%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 55.70% on 04/10/25
  • IV Low 19.71% on 12/26/24
  • Put/Call Vol Ratio 1.31
  • Today's Volume 58,190
  • Volume Avg (30-Day) 31,218
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 587,965
  • Open Int (30-Day) 567,227

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.54
  • Number of Estimates 10
  • High Estimate 1.71
  • Low Estimate 1.43
  • Prior Year -4.40
  • Growth Rate Est. (year over year) +135.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.82 +3.36%
on 04/10/25
Period Open: 63.11
63.33 -20.32%
on 03/11/25
-12.65 (-20.04%)
since 03/10/25
3-Month
48.82 +3.36%
on 04/10/25
Period Open: 55.83
63.33 -20.32%
on 03/11/25
-5.37 (-9.62%)
since 01/10/25
52-Week
39.35 +28.23%
on 07/05/24
Period Open: 50.29
63.33 -20.32%
on 03/11/25
+0.17 (+0.34%)
since 04/10/24

Most Recent Stories

More News
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

CORT : 67.73 (-7.18%)
SUPN : 31.07 (-2.17%)
LLY : 720.91 (-4.35%)
ZTS : 147.00 (-4.27%)
BMY : 50.46 (-6.10%)
Wall Street's euphoria sends US stocks to historic gains after Trump pauses most of his tariffs

U.S. stocks soared to one of their best days in history on a euphoric Wall Street after President Donald Trump said he would back off on most of his tariffs temporarily

$SPX : 5,268.05 (-3.46%)
JNJ : 148.69 (-1.51%)
BAX : 28.14 (-8.49%)
$DOWI : 39,593.66 (-2.50%)
$IUXX : 18,343.57 (-4.19%)
PFE : 21.59 (-4.00%)
DAL : 39.36 (-11.09%)
BMY : 50.46 (-6.10%)
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 44.51 (-11.46%)
GOOGL : 152.82 (-3.71%)
MPC : 121.53 (-7.53%)
AAPL : 190.42 (-4.24%)
JNJ : 148.69 (-1.51%)
AMGN : 281.41 (-3.33%)
PFE : 21.59 (-4.00%)
OXY : 36.47 (-9.35%)
TSLA : 252.40 (-7.27%)
FANG : 123.16 (-8.72%)
AMD : 88.70 (-8.41%)
SPY : 524.58 (-4.38%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 44.51 (-11.46%)
GOOGL : 152.82 (-3.71%)
MPC : 121.53 (-7.53%)
AAPL : 190.42 (-4.24%)
ADI : 178.36 (-9.29%)
JNJ : 148.69 (-1.51%)
AMGN : 281.41 (-3.33%)
PFE : 21.59 (-4.00%)
OXY : 36.47 (-9.35%)
TSLA : 252.40 (-7.27%)
FANG : 123.16 (-8.72%)
AMD : 88.70 (-8.41%)
Bristol Myers Wins Dismissal Of Class Action Lawsuit Accusing It Of Fraudulently Acquiring Patents – Retail Sentiment Remains Subdued

U.S. District Judge Edgardo Ramos in Manhattan said the plaintiffs failed to show that Bristol Myers and Celgene Corp violated the federal Sherman antitrust law.

VOO : 482.06 (-3.41%)
VTI : 257.43 (-4.12%)
BMY : 50.46 (-6.10%)
Is Pfizer Stock a Buy?

Pfizer 's (NYSE: PFE) share price has fallen more than the S&P 500 so far this year. The big pharma stock is nearly 60% below its high set in late 2022. By most standards, Pfizer looks like the proverbial...

PFE : 21.59 (-4.00%)
BMY : 50.46 (-6.10%)
Is Bristol Myers Squibb's High-Yielding Dividend Safe?

High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on a high yield can be dangerous because if it ends up getting cut, you could lose...

BMY : 50.46 (-6.10%)
Stocks Finish Higher as Magnificent Seven Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. June E-mini S&P...

ALK : 44.51 (-11.46%)
GOOGL : 152.82 (-3.71%)
UAL : 62.75 (-11.41%)
AAPL : 190.42 (-4.24%)
PVH : 69.15 (-2.19%)
ADI : 178.36 (-9.29%)
JNJ : 148.69 (-1.51%)
MRK : 77.55 (-5.32%)
TXN : 156.60 (-7.61%)
$IUXX : 18,343.57 (-4.19%)
PFE : 21.59 (-4.00%)
ZNM25 : 110-035 (-0.44%)
Beat the S&P 500 With This Cash-Gushing Dividend Stock

Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY) . At the time of writing, shares of the healthcare giant have climbed 4% year to date...

BMY : 50.46 (-6.10%)
FDA Expands Exelixis Cabometyx Label for Neuroendocrine Tumors

Exelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib).The regulatory body approved Cabometyx for the treatment of adult and pediatric patients...

BAYRY : 5.6300 (-1.75%)
NVO : 61.21 (-5.96%)
EXEL : 34.46 (-2.49%)
BMY : 50.46 (-6.10%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 57.58
2nd Resistance Point 55.50
1st Resistance Point 52.98
Last Price 50.46
1st Support Level 48.38
2nd Support Level 46.30
3rd Support Level 43.78

See More

52-Week High 63.33
Fibonacci 61.8% 54.17
Fibonacci 50% 51.34
Last Price 50.46
Fibonacci 38.2% 48.51
52-Week Low 39.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar